Login Register Cart 0
Generic placeholder image

Reviews on Recent Clinical Trials

Editor-in-Chief

ISSN (Print): 1574-8871
ISSN (Online): 1876-1038

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease

Author(s): Annamaria Spina, Chiara Mazzarella, Marcello Dallio, Mario Romeo, Raffaele Pellegrino, Tommaso Durante, Marco Romano, Carmelina Loguercio, Maurizio Di Mauro, Alessandro Federico and Antonietta Gerarda Gravina*

Volume 17, Issue 2, 2022

Published on: 28 June, 2022

Page: [109 - 119] Pages: 11

DOI: 10.2174/1574887117666220328125720

Price: $65

Abstract

Background: During the COVID-19 pandemic in Italy, decisions were taken to adopt restrictive legislative measures, such as the first half of the 2020 lockdown. In those months, patients with inflammatory bowel disease experienced social isolation and reduced access to health care.

Objective: We aimed to evaluate, in this condition, the presence of remission subgroups that were most impacted by the lockdown.

Methods: During the first Italian lockdown, we recruited patients with remission of inflammatory bowel disease by administering an online questionnaire including patient demographics, the Beck Anxiety Questionnaire Inventory, the Beck Depression Inventory questionnaire, and the Pittsburg Sleep Quality Index, all validated standardized questionnaires for anxiety symptom levels, depression, and sleep quality.

Results: Our results showed how female patients (p<0.0001) with Crohn’s disease (p<0.001) experienced worse levels of anxiety symptoms. Female patients (p<0.0001) between 50 and 60 years of age (p=0.013) with Crohn’s disease (p=0.047) experienced worse levels of depressive symptoms. Females also experienced significantly worse sleep levels (p<0.001). We found a correlation between the number of sleeping hours (p<0.001) and the time taken to fall asleep (p<0.001) and the Beck Anxiety Questionnaire Inventory,which showed a linear worsening of the number of minutes it took to fall asleep, and the Beck Depression Inventory questionnaire.

Conclusion: Among patients with remission of inflammatory bowel disease, female patients, patients with Crohn’s disease, and people aged between 50 and 70 years should be considered for screening for anxiety and depression disorders and an assessment of sleep quality.

Keywords: COVID-19, anxiety, depression, sleep quality, Crohn’s disease, ulcerative colitis, IBD, lockdown.

« Previous Next »
Graphical Abstract

[1]
Giovanetti, M.; Benedetti, F.; Campisi, G. Evolution patterns of SARS-CoV-2: Snapshot on its genome variants. Biochem. Biophys. Res. Commun., 2021, 538, 88-91.
[http://dx.doi.org/10.1016/j.bbrc.2020.10.102] [PMID: 33199021]
[2]
Jayaweera, M.; Perera, H.; Gunawardana, B.; Manatunge, J. Transmission of COVID-19 virus by droplets and aerosols: A critical review on the unresolved dichotomy. Environ. Res., 2020, 188, 109819.
[http://dx.doi.org/10.1016/j.envres.2020.109819] [PMID: 32569870]
[3]
Chan, J.F.W.; Yuan, S.; Kok, K.H. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster. Lancet, 2020, 395(10223), 514-523.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]
[4]
Abenavoli, L.; Cinaglia, P.; Procopio, A.C. SARS-CoV-2 spread dynamics in Italy: The Calabria experience. Rev. Recent Clin. Trials, 2021, 16(3), 309-315.
[http://dx.doi.org/10.2174/1574887116666210401124945] [PMID: 33797377]
[5]
FAO Decree of the President of the Council of Ministers. Further implementing provisions of the decree-law 23 February 2020, n. 6, containing urgent measures regarding the containment and management of the epidemiological emergency from COVID-19, applicable throughout the country; Available from, 2020. https://www.fao.org/faolex/results/details/en/c/LEX-FAOC194202/
[6]
Holt-Lunstad, J.; Smith, T.B.; Baker, M.; Harris, T.; Stephenson, D. Loneliness and social isolation as risk factors for mortality: A meta-analytic review. Perspect. Psychol. Sci., 2015, 10(2), 227-237.
[http://dx.doi.org/10.1177/1745691614568352] [PMID: 25910392]
[7]
Ho, F.Y.Y.; Chan, C.S.; Lo, W.Y.; Leung, J.C.Y. The effect of self-help cognitive behavioral therapy for insomnia on depressive symptoms: An updated meta-analysis of randomized controlled trials. J. Affect. Disord., 2020, 265, 287-304.
[http://dx.doi.org/10.1016/j.jad.2020.01.062] [PMID: 32090753]
[8]
Kim, M.C.; Jung, Y.S.; Song, Y.S. Factors associated with anxiety and depression in Korean patients with inactive inflammatory bowel disease. Gut Liver, 2016, 10(3), 399-405.
[http://dx.doi.org/10.5009/gnl15188] [PMID: 26470768]
[9]
Kim, E.S.; Cho, K.B.; Park, K.S. Predictive factors of impaired quality of life in Korean patients with inactive inflammatory bowel disease: Association with functional gastrointestinal disorders and mood disorders. J. Clin. Gastroenterol., 2013, 47(4), e38-e44.
[http://dx.doi.org/10.1097/MCG.0b013e318266fff5] [PMID: 23090047]
[10]
Liu, S.; Ren, J.; Hong, Z. An evil backstage manipulator: Psychological factors correlated with health-related quality of life in Chinese patients with Crohn’s disease. ScientificWorldJournal, 2013, 2013, 1-9.
[http://dx.doi.org/10.1155/2013/464698] [PMID: 24453858]
[11]
Neuendorf, R.; Harding, A.; Stello, N.; Hanes, D.; Wahbeh, H. Depression and anxiety in patients with inflammatory Bowel disease: A systematic review. J. Psychosom. Res., 2016, 87, 70-80.
[http://dx.doi.org/10.1016/j.jpsychores.2016.06.001] [PMID: 27411754]
[12]
Loftus, E.V., Jr; Guérin, A.; Yu, A.P. Increased risks of developing anxiety and depression in young patients with Crohn’s disease. Am. J. Gastroenterol., 2011, 106(9), 1670-1677.
[http://dx.doi.org/10.1038/ajg.2011.142] [PMID: 21537359]
[13]
Kappelman, M.D.; Long, M.D.; Martin, C. Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases. Clin. Gastroenterol. Hepatol., 2014, 12(8), 1315-1323.e2.
[http://dx.doi.org/10.1016/j.cgh.2013.10.019] [PMID: 24183956]
[14]
Byrne, G.; Rosenfeld, G.; Leung, Y. Prevalence of anxiety and depression in patients with inflammatory bowel disease. Can. J. Gastroenterol. Hepatol., 2017, 2017, 1-6.
[http://dx.doi.org/10.1155/2017/6496727] [PMID: 29181373]
[15]
Wintjens, D.S.J.; de Jong, M.J.; van der Meulen-de Jong, A.E. Novel perceived stress and life events precede flares of inflammatory bowel disease: A prospective 12-month follow-up study. J. Crohn’s Colitis, 2019, 13(4), 410-416.
[http://dx.doi.org/10.1093/ecco-jcc/jjy177] [PMID: 30371776]
[16]
Beck, A.T.; Epstein, N.; Brown, G.; Steer, R.A. An inventory for measuring clinical anxiety: Psychometric properties. J. Consult. Clin. Psychol., 1988, 56(6), 893-897.
[http://dx.doi.org/10.1037/0022-006X.56.6.893] [PMID: 3204199]
[17]
Aaron Temkin Beck Depression: causes and treatment, 2nd ed; Pennsylvania Press: NY, 2008.
[18]
Buysse, D.J.; Reynolds, C.F., III; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh sleep quality index: A new instrument for psychiatric prac-tice and research. Psychiatry Res., 1989, 28(2), 193-213.
[http://dx.doi.org/10.1016/0165-1781(89)90047-4] [PMID: 2748771]
[19]
Navabi, S.; Gorrepati, V.S.; Yadav, S. Influences and impact of anxiety and depression in the setting of inflammatory bowel disease. Inflamm. Bowel Dis., 2018, 24(11), 2303-2308.
[http://dx.doi.org/10.1093/ibd/izy143] [PMID: 29788469]
[20]
Fuller-Thomson, E.; Lateef, R.; Sulman, J. Robust association between inflammatory bowel disease and generalized anxiety disorder. Inflamm. Bowel Dis., 2015, 21(10), 1.
[http://dx.doi.org/10.1097/MIB.0000000000000518] [PMID: 26218145]
[21]
Nahon, S.; Lahmek, P.; Durance, C. Risk factors of anxiety and depression in inflammatory bowel disease. Inflamm. Bowel Dis., 2012, 18(11), 2086-2091.
[http://dx.doi.org/10.1002/ibd.22888] [PMID: 22294486]
[22]
Goodhand, J.R.; Wahed, M.; Mawdsley, J.E.; Farmer, A.D.; Aziz, Q.; Rampton, D.S. Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm. Bowel Dis., 2012, 18(12), 2301-2309.
[http://dx.doi.org/10.1002/ibd.22916] [PMID: 22359369]
[23]
Graff, L.A.; Vincent, N.; Walker, J.R. A population-based study of fatigue and sleep difficulties in inflammatory bowel disease. Inflamm. Bowel Dis., 2011, 17(9), 1882-1889.
[http://dx.doi.org/10.1002/ibd.21580] [PMID: 21830266]
[24]
Graff, L.A.; Walker, J.R.; Russell, A.S.; Bissonnette, R.; Bernstein, C.N. Fatigue and quality of sleep in patients with immune-mediated inflammato-ry disease. J. Rheumatol. Suppl., 2011, 88(0), 36-42.
[http://dx.doi.org/10.3899/jrheum.110902] [PMID: 22045977]
[25]
Kaptchuk, T.J. The placebo effect in alternative medicine: Can the performance of a healing ritual have clinical significance? Ann. Intern. Med., 2002, 136(11), 817-825.
[http://dx.doi.org/10.7326/0003-4819-136-11-200206040-00011] [PMID: 12044130]
[26]
Kluger, M.T.; Owen, H. Patient-controlled analgesia: Can it be made safer? Anaesth. Intensive Care, 1991, 19(3), 412-420.
[http://dx.doi.org/10.1177/0310057X9101900319] [PMID: 1767912]
[27]
van den Brink, G.; Stapersma, L.; El Marroun, H. Effectiveness of disease-specific cognitive–behavioural therapy on depression, anxie-ty, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre ran-domised controlled trial (HAPPY-IBD). BMJ Open Gastroenterol., 2016, 3(1), e000071.
[http://dx.doi.org/10.1136/bmjgast-2015-000071] [PMID: 26966551]
[28]
Stapersma, L.; van den Brink, G.; van der Ende, J. Psychological outcomes of a cognitive behavioral therapy for youth with inflammato-ry bowel disease: Results of the HAPPY-IBD randomized controlled Trial at 6- and 12-month follow-up. J. Clin. Psychol. Med. Settings, 2020, 27(3), 490-506.
[http://dx.doi.org/10.1007/s10880-019-09649-9] [PMID: 31506853]
[29]
Marinelli, C.; Savarino, E.V.; Marsilio, I. Sleep disturbance in inflammatory bowel disease: Prevalence and risk factors – A cross-sectional study. Sci. Rep., 2020, 10(1), 507.
[http://dx.doi.org/10.1038/s41598-020-57460-6] [PMID: 31949257]
[30]
Wang, H.; Tu, L.; Li, Y. The symptoms and medications of patients with inflammatory bowel disease in Hubei province after COVID-19 epidemic. J. Immunol. Res., 2020, 2020, 1-7.
[http://dx.doi.org/10.1155/2020/2847316] [PMID: 33062719]
[31]
Graff, L.A.; Walker, J.R.; Clara, I. Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls. Am. J. Gastroenterol., 2009, 104(12), 2959-2969.
[http://dx.doi.org/10.1038/ajg.2009.529] [PMID: 19755973]
[32]
Tayefi, M.; Shafiee, M.; Kazemi-Bajestani, S.M.R. Depression and anxiety both associate with serum level of hs-CRP: A gender-stratified analysis in a population-based study. Psychoneuroendocrinology, 2017, 81, 63-69.
[http://dx.doi.org/10.1016/j.psyneuen.2017.02.035] [PMID: 28419913]
[33]
Miller, G.E.; Stetler, C.A.; Carney, R.M.; Freedland, K.E.; Banks, W.A. Clinical depression and inflammatory risk markers for coronary heart dis-ease. Am. J. Cardiol., 2002, 90(12), 1279-1283.
[http://dx.doi.org/10.1016/S0002-9149(02)02863-1] [PMID: 12480034]
[34]
O’Brien, S.M.; Scott, L.V.; Dinan, T.G. Antidepressant therapy and C-reactive protein levels. Br. J. Psychiatry, 2006, 188(5), 449-452.
[http://dx.doi.org/10.1192/bjp.bp.105.011015] [PMID: 16648531]
[35]
Müller, N. Immunology of major depression. Neuroimmunomodulation, 2014, 21(2-3), 123-130.
[http://dx.doi.org/10.1159/000356540] [PMID: 24557045]
[36]
Häuser, W.; Janke, K.H.; Klump, B.; Hinz, A. Anxiety and depression in patients with inflammatory bowel disease. Inflamm. Bowel Dis., 2011, 17(2), 621-632.
[http://dx.doi.org/10.1002/ibd.21346] [PMID: 20848528]
[37]
Bernstein, C.N.; Singh, S.; Graff, L.A.; Walker, J.R.; Miller, N.; Cheang, M. A prospective population-based study of triggers of symptomatic flares in IBD. Am. J. Gastroenterol., 2010, 105(9), 1994-2002.
[http://dx.doi.org/10.1038/ajg.2010.140] [PMID: 20372115]
[38]
Bitton, A.; Sewitch, M.J.; Peppercorn, M.A. Psychosocial determinants of relapse in ulcerative colitis: A longitudinal study. Am. J. Gastroenterol., 2003, 98(10), 2203-2208.
[http://dx.doi.org/10.1111/j.1572-0241.2003.07717.x] [PMID: 14572569]
[39]
Mawdsley, J.E.; Rampton, D.S. Psychological stress in IBD: New insights into pathogenic and therapeutic implications. Gut, 2005, 54(10), 1481-1491.
[http://dx.doi.org/10.1136/gut.2005.064261] [PMID: 16162953]
[40]
Bitton, A.; Dobkin, P.L.; Edwardes, M.D. Predicting relapse in Crohn’s disease: A biopsychosocial model. Gut, 2008, 57(10), 1386-1392.
[http://dx.doi.org/10.1136/gut.2007.134817] [PMID: 18390994]
[41]
Levenstein, S.; Prantera, C.; Varvo, V. Stress and exacerbation in ulcerative colitis: A prospective study of patients enrolled in remission. Am. J. Gastroenterol., 2000, 95(5), 1213-1220.
[http://dx.doi.org/10.1111/j.1572-0241.2000.02012.x] [PMID: 10811330]
[42]
Ishihara, K.; Izawa, K.P.; Noto, S.; Shimizu, I. Physical and mental functions of cardiovascular diseased patients decrease during the state of emergency initiated by the COVID-19 pandemic in Japan. Rev. Recent Clin. Trials, 2021, 16(3), 316-321.
[http://dx.doi.org/10.2174/1574887116666210316110127] [PMID: 33726657]
[43]
Abenavoli, L.; Cinaglia, P.; Lombardo, G. Anxiety and gastrointestinal symptoms related to COVID-19 during Italian lockdown. J. Clin. Med., 2021, 10(6), 1221.
[http://dx.doi.org/10.3390/jcm10061221] [PMID: 33809403]
[44]
Larussa, T.; Abenavoli, L.; Corea, A. Trends and characteristics associated with dietary triggers and psychological distress in patients with irritable bowel syndrome: A cross-sectional study. Eur. Rev. Med. Pharmacol. Sci., 2021, 25(10), 3752-3761.
[PMID: 34109584]

Rights & Permissions Print Cite
Article Metrics
7
© 2024 Bentham Science Publishers | Privacy Policy